Nonculprit Disease in Non-ST-Segment Elevation Myocardial Infarction and Cardiogenic Shock
- PMID: 33933389
- DOI: 10.1016/j.jcin.2021.03.064
Nonculprit Disease in Non-ST-Segment Elevation Myocardial Infarction and Cardiogenic Shock
Keywords: cardiogenic shock; complete revascularization; myocardial infarction.
Conflict of interest statement
Funding Support and Author Disclosures Dr. Iqbal has received funding, honoraria, and consulting fees from AstraZeneca, Novartis, St. Jude Medical, Terumo Medical, and the British Heart Foundation.
Comment on
-
Multivessel Versus Culprit-Vessel Percutaneous Coronary Intervention in Patients With Non-ST-Segment Elevation Myocardial Infarction and Cardiogenic Shock.JACC Cardiovasc Interv. 2021 May 24;14(10):1067-1078. doi: 10.1016/j.jcin.2021.02.021. Epub 2021 Apr 28. JACC Cardiovasc Interv. 2021. PMID: 33933384
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources